Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative pain control after elective open liver or pancreatic surgery: intrathecal morphine versus On-Q incisional catheters
2019-001502-23Phase 4Active
- Sponsor
- Rafael Uña
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of morphine hydrochloride, levobupivacaine, bupivacaine and lidocaine in postoperative pain (2 arms), sponsored by Rafael Uña. Primary endpoint: Pain intensity at 24 hours after surgery. Started Jul 2019; status: active.
02
Drugs
morphine hydrochloridelevobupivacainebupivacainelidocaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2019-001502-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001502-23.